In conclusion, here we show that BaP is capable of promoting a HCC-like scenario in HepG2 through AhR-mediated and genotoxic mechanisms, with impairment of important liver attributions and induction of notoriously poor prognostic features in neoplasms. This evidence concerns the gene AHR and neoplasm.